Issued Patents 2019
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10517866 | Removing senescent cells from a mixed cell population or tissue using a phosphoinositide 3-kinase (PI3K) inhibitor | Remi-Martin Laberge, James L. Kirkland, Tamar Tchkonia, Yi Zhu, Alain P. Vasserot +3 more | 2019-12-31 |
| 10478433 | Unit dose of an aryl sulfonamide that is effective for treating eye disease and averting potential vision loss | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Darren J. Baker, James L. Kirkland +5 more | 2019-11-19 |
| 10478432 | Compositions of matter for treatment of ophthalmic conditions by selectively removing senescent cells from the eye | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Alain P. Vasserot, James L. Kirkland +5 more | 2019-11-19 |
| 10434108 | Synthetic bile acid compositions and methods | Robert M. Moriarty, Nadir Ahmeduddin Mahmood | 2019-10-08 |
| 10434107 | Synthetic bile acid compositions and methods | Robert M. Moriarty, Nadir Ahmeduddin Mahmood | 2019-10-08 |
| 10426788 | Chemical entities that kill senescent cells for use in treating age-related disease | — | 2019-10-01 |
| 10413542 | Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders using an inhibitor of Akt kinase | Remi-Martin Laberge, Alain P. Vasserot, Darren J. Baker, Bennett G. Childs, James L. Kirkland +3 more | 2019-09-17 |
| 10378002 | Replication conditional virus that specifically kills senescent cells | Serge Lichtsteiner | 2019-08-13 |
| 10328073 | Use of sulfonamide inhibitors of BCL-2 and BCL-xL to treat ophthalmic disease by selectively removing senescent cells | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Alain P. Vasserot, James L. Kirkland +5 more | 2019-06-25 |
| 10328058 | Treating atherosclerosis by removing senescent foam cell macrophages from atherosclerotic plaques | Darren J. Baker, Marco Demaria, Albert Davalos, Bennett G. Childs, Jan M.A. van Deursen +5 more | 2019-06-25 |
| 10258618 | Treating pulmonary conditions by selectively removing senescent cells from the lung using an intermittent dosing regimen | Remi-Martin Laberge, Judith Campisi, Marco Demaria, Darren J. Baker, James L. Kirkland +3 more | 2019-04-16 |
| 10213426 | Method of optimizing conditions for selectively removing a plurality of senescent cells from a tissue or a mixed cell population | Remi-Martin Laberge, Judith Campisi, Albert Davalos, Marco Demaria, Yi Zhu +2 more | 2019-02-26 |
| 10195213 | Chemical entities that kill senescent cells for use in treating age-related disease | — | 2019-02-05 |